| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/29/2013 | CN102399284B Fox growth hormone releasing hormone cDNA and its application |
| 05/29/2013 | CN102399283B Mink growth hormone releasing hormone cDNA and application thereof |
| 05/29/2013 | CN102219750B N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase |
| 05/29/2013 | CN102161991B Single-strand multi-target interfering nucleic acid molecule and application thereof |
| 05/29/2013 | CN102026664B Composition for stabilizing Beta-blocker, and transdermally absorbable preparation comprising the composition |
| 05/29/2013 | CN101978054B Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 05/29/2013 | CN101506145B Aminoalcohol derivative and immunosuppressant containing the same as active ingredient |
| 05/28/2013 | US8450470 Use to faciliate drug delivery of other drugs, or treat glycosaminoglycan associated pathologies, such as scarring, spinal cord injury, glaucoma, and cosmetic treatments |
| 05/28/2013 | US8450352 Thiazole compounds and their use for inhibiting phosphodiesterase 4, TNF-α, and IL-4 |
| 05/28/2013 | US8450288 For introduction of a disc prosthesis or implant; involves providing substance(s) beneficial to the intervertebral disc through a cannulated element |
| 05/28/2013 | US8449911 Drug composition having active ingredient adhered at high concentration to spherical core |
| 05/28/2013 | CA2623958C 2-heteroaryl-substituted indole derivative |
| 05/28/2013 | CA2598301C Salt of proline derivative, solvate thereof, and production method thereof |
| 05/28/2013 | CA2547887C Protein modifier production inhibitor |
| 05/28/2013 | CA2506581C Novel 2',5'-oligoadenylic acid analogues |
| 05/28/2013 | CA2490452C .beta.-glucan-containing fat and oil composition and novel microorganism capable of producing .beta.-glucan |
| 05/28/2013 | CA2485346C Human adam-10 inhibitors |
| 05/28/2013 | CA2483145C Transgenic plants with controlled distribution of a trait to progeny |
| 05/28/2013 | CA2476773C Monoclonal antibodies against extracellular loops of c5ar |
| 05/28/2013 | CA2464353C Linear basic compounds having nk-2 antagonist activity and formulations thereof |
| 05/28/2013 | CA2459769C Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses |
| 05/28/2013 | CA2448620C Vaccination against the feline immunodeficiency virus |
| 05/28/2013 | CA2443372C Immunotherapeutic combinations for the treatment of tumors that over-express gangliosides |
| 05/28/2013 | CA2427661C Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants |
| 05/28/2013 | CA2323210C Enhancement of intracellular delivery and tissue targeting of drugs and genes |
| 05/28/2013 | CA2240292C Recombinant fusion proteins to growth hormone and serum albumin |
| 05/23/2013 | WO2013073698A1 Cxcr4 activity inhibiting peptide and application thereof |
| 05/23/2013 | WO2013073602A1 Nucleic acid fragment binding to target protein |
| 05/23/2013 | WO2013073577A1 Dihydroxy aromatic heterocyclic compound |
| 05/23/2013 | WO2013073382A1 Drug for treatment or prevention of nephropathy |
| 05/23/2013 | WO2013071715A1 Histone deacetylase inhibitors and synthetic method thereof and use thereof in manufacture of medicaments |
| 05/23/2013 | US20130131338 Substituted diketopiperazines as oxytocin antagonists |
| 05/23/2013 | US20130131317 Expression of secreted human alpha-fetoprotein in transgenic animals |
| 05/23/2013 | US20130131125 Therapeutic combination |
| 05/23/2013 | US20130131123 Oral Dosage Form Containing A Pde 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidon As Excipient |
| 05/23/2013 | US20130131071 Use of pteridine derivatives for the treatment of increased intracranial pressure, secondary ischemia, and disorders associated with an increased level of cytotoxic reactive oxygen species |
| 05/23/2013 | US20130129717 Monoclonal Antibodies Against Extracellular Loops of C5aR |
| 05/23/2013 | CA2856288A1 Nucleic acid fragment binding to target protein |
| 05/22/2013 | EP2594566A1 Nitrogenated aromatic heterocyclic ring derivative |
| 05/22/2013 | EP2594559A1 Pyrazole compound |
| 05/22/2013 | EP2594555A1 HETEROCYCLIC COMPOUND, AND p27 KIP1 DEGRADATION INHIBITOR |
| 05/22/2013 | EP2594274A1 Novel hyaluronic acid decomposition-promoting factor and inhibitor thereof |
| 05/22/2013 | EP2594267A1 Protective Agent for Retinal Nerve or Optic Nerve |
| 05/22/2013 | EP2593425A1 Therapeutically active compositions and their method of use |
| 05/22/2013 | EP2593112A2 Novel antibacterial compounds, methods of making them, and uses thereof |
| 05/22/2013 | CN1655673B Methods and compositions for treating ectoparasite infestation |
| 05/22/2013 | CN1652754B Tasted masked veterinary solid compositions |
| 05/22/2013 | CN1384759B Single-stranded oligodeoxynucleotide mutation vectors |
| 05/22/2013 | CN103119166A Prophylactic or therapeutic agent for fibrosis |
| 05/22/2013 | CN103119031A 取代酰胺化合物 Substituted amide compounds |
| 05/22/2013 | CN103119024A Isoquinoline derivative |
| 05/22/2013 | CN103118687A Cytoprotective agent |
| 05/22/2013 | CN103118675A Fat and oil composition for promoting insulin secretion |
| 05/22/2013 | CN103118661A Method for controlling hair growth, method for selecting or evaluating hair growth control agent, and hair growth suppression agent |
| 05/22/2013 | CN103110858A Anti-transport-stress medicament for goats and application thereof |
| 05/22/2013 | CN103110779A Composition containing Chinese yam and application thereof |
| 05/22/2013 | CN103110702A Navel-warming paste capable of warming spleen and stomach for dispelling cold and preparation method thereof |
| 05/22/2013 | CN103110690A Chinese herbal medicine compound preparation for treating infant and night sweat |
| 05/22/2013 | CN103110566A External pigmentum for correcting bad habit of finger sucking of infants |
| 05/22/2013 | CN102430046B Aquatic product alive-keeping agent and preparation method and application thereof |
| 05/22/2013 | CN102397393B Compound propolis composition for treating sudden death syndrome in poultry, and preparation method thereof |
| 05/22/2013 | CN102349950B Food, health product or pharmaceutical composition as well as preparation method and application thereof |
| 05/22/2013 | CN102343034B Composition applied to side effects caused by tumor radiation and pharyngitis as well as preparing method thereof |
| 05/22/2013 | CN101897662B Ophtalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent |
| 05/22/2013 | CN101678047B Remedy and diagnostic agent for mitochondrial dysfunction brain disease |
| 05/21/2013 | US8445479 Staurosporine derivatives as inhibitors of FLT3 receptor tyrosine kinase activity |
| 05/21/2013 | US8445425 Urocortin-III and uses thereof |
| 05/21/2013 | US8445237 RNA interference mediating small RNA molecules |
| 05/21/2013 | US8445234 Methods of making VEGF-D polypeptides |
| 05/21/2013 | US8445233 PGC-1β, a novel PGC-1 homologue and uses therefor |
| 05/21/2013 | US8444990 Antibody-induced apoptosis |
| 05/21/2013 | US8444988 Cancer treatment method |
| 05/21/2013 | US8444979 Antibodies that inhibit TSLP activity |
| 05/21/2013 | US8443799 Dry powder inhalation system for transpulmonary administration |
| 05/21/2013 | CA2560209C Tissue repair |
| 05/21/2013 | CA2454147C Inhibitor of dna methylation |
| 05/21/2013 | CA2412436C Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury |
| 05/21/2013 | CA2399080C Humanized anti-ccr2 antibodies and methods of use therefor |
| 05/21/2013 | CA2397987C Use of at least a fatty ester for preparing a composition designed to inhibit 5 alpha reductase activity, in pharmacology, in particular dermatology, in cosmetics and as food additive |
| 05/21/2013 | CA2396688C Glycosidase inhibitors and methods of synthesizing same |
| 05/21/2013 | CA2360146C Methods for inhibiting brain tumor growth by using selected integrin antagonists |
| 05/16/2013 | WO2013069765A1 Nitrogenated heterocyclic compound |
| 05/16/2013 | WO2013069339A1 Puncture pain alleviating external preparation |
| 05/16/2013 | WO2013067710A1 Nampt inhibitors |
| 05/16/2013 | US20130125259 Rna interference mediating small rna molecules |
| 05/16/2013 | US20130123251 Benzoxazine derivatives and uses thereof |
| 05/16/2013 | US20130123170 Growth Hormone Releasing Peptides |
| 05/16/2013 | US20130122295 Allergen suppressor, allergen-suppression processed fiber and method of producing the same |
| 05/16/2013 | US20130122115 Rebound hoof pack |
| 05/16/2013 | CA2855510A1 Nampt inhibitors |
| 05/15/2013 | EP2592088A1 Cyclic peptide compound or pharmacologically acceptable salt thereof and method for producing same |
| 05/15/2013 | EP2592081A1 Tetrahydrocarboline derivative |
| 05/15/2013 | EP2592080A1 Crystal of fused pyridine compound salt |
| 05/15/2013 | EP2592076A1 Substituted pyridine compound |
| 05/15/2013 | EP2591806A1 Medicinal composition |
| 05/15/2013 | EP2591790A1 T cell apoptosis inducer |
| 05/15/2013 | EP2591784A1 Pyridine-2-one-derivatives as modulators of stress-activated protein kinase system |
| 05/15/2013 | EP2591777A2 L-NIL as inhibitor for regenerating the lung of a patient suffering from COPD |
| 05/15/2013 | EP2591776A1 Use of kukoamine a and kukoamine b |
| 05/15/2013 | EP2590644A1 Sn-2-monoacylglycerols and lipid malabsorption |